ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Cambrex expands its Swedish plant

by Rick Mullin
June 5, 2017 | APPEARED IN VOLUME 95, ISSUE 23

[+]Enlarge
Credit: Cambrex
Cambrex is expanding this facility in Karlskoga, Sweden.
Credit: Cambrex
Cambrex is expanding this facility in Karlskoga, Sweden.

Cambrex is expanding its large-scale active pharmaceutical ingredient operation in Karlskoga, Sweden, introducing continuous-flow production of high-purity drug intermediates. The expansion will also add multipurpose batch reactors ranging from 4 to 12 m3, a 9-m3 hydrogenation reactor, and an upgraded control room. Work on the project is set to be completed later this year.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment